FDA seeks feedback on regulating generative AI-enabled medical devices in new discussion paper
emmanuelvivier · x · 2026-08-22
The FDA's Digital Health Center of Excellence has published a discussion paper, "Considerations for the Regulation of Generative AI-Enabled Medical Devices," requesting stakeholder feedback. It notes GenAI-enabled devices hold transformative promise for patient care but may introduce unique risks compared to traditional software and AI-enabled devices.
Topics covered, each with questions:
- Risk assessment considerations for GenAI-enabled devices
- Premarket evaluation approaches
- Postmarket surveillance, including agentic models
Related event: FDA Seeks Public Input on Generative AI Medical Device Regulation(2 posts)→
More from Safety
- Anthropic red team's first-ever model "abliteration" cut GLM-5.3 refusals from 90% to 3% for ~$4,400 — cephaloform · 2026-10-16
- Anthropic grants METR employee-like access as independent safety evaluators go public — AnthropicAI · 2026-10-16
- APEX-Harm benchmark: script-based injection attacks easily compromise agents in shared workspaces — KAUST · 2026-10-16
- Residual-stream forecasts predict agent violations before they happen, USC study shows — USC · 2026-10-16
- AI safety drama: risk research called a 'company effort,' team lead responds — logangraham · 2026-10-16
- Brave's Leo adds end-to-end encrypted chat with GLM via attested TEE — gnukeith · 2026-10-16